Myelotoxicity Following High-Dose Methotrexate in Children with Down Syndrome and Acute Lymphoblastic Leukemia

C. Bohnstedt; M. Levinsen; S. Rosthøj; B. Zeller; M. Taskinen; S. Hafsteinsdottir; H. Bjorgvinsdottir; M. Heymann; K. Schmiegelow

doi:10.1002/pbc.27455

Myelotoxicity Following High-Dose Methotrexate in Children with Down Syndrome and Acute Lymphoblastic Leukemia

C. Bohnstedt, M. Levinsen, S. Rosthøj, B. Zeller, M. Taskinen, S. Hafsteinsdottir, H. Bjorgvinsdottir, M. Heymann, K. Schmiegelow

1 Citation (Scopus)

Original language	English
Book series	Medical and Pediatric Oncology. Supplement
Volume	65
Pages (from-to)	S104
Number of pages	1
ISSN	1545-5009
DOIs	https://doi.org/10.1002/pbc.27455
Publication status	Published - 2018

Access to Document

10.1002/pbc.27455

Myelotoxicity Following High-Dose Methotrexate in Children with Down Syndrome and Acute Lymphoblastic LeukemiaFinal published version, 7.19 MB

Cite this

@article{6475af36738b448b957a15e12470f896,

title = "Myelotoxicity Following High-Dose Methotrexate in Children with Down Syndrome and Acute Lymphoblastic Leukemia",

author = "C. Bohnstedt and M. Levinsen and S. Rosth{\o}j and B. Zeller and M. Taskinen and S. Hafsteinsdottir and H. Bjorgvinsdottir and M. Heymann and K. Schmiegelow",

note = "Abstract PO-020",

year = "2018",

doi = "10.1002/pbc.27455",

language = "English",

volume = "65",

pages = "S104",

journal = "Medical and Pediatric Oncology. Supplement",

issn = "0740-8226",

publisher = "JohnWiley & Sons, Inc.",

}

TY - ABST

T1 - Myelotoxicity Following High-Dose Methotrexate in Children with Down Syndrome and Acute Lymphoblastic Leukemia

AU - Bohnstedt, C.

AU - Levinsen, M.

AU - Rosthøj, S.

AU - Zeller, B.

AU - Taskinen, M.

AU - Hafsteinsdottir, S.

AU - Bjorgvinsdottir, H.

AU - Heymann, M.

AU - Schmiegelow, K.

N1 - Abstract PO-020

PY - 2018

Y1 - 2018

U2 - 10.1002/pbc.27455

DO - 10.1002/pbc.27455

M3 - Conference abstract in journal

C2 - 30240102

SN - 0740-8226

VL - 65

SP - S104

JO - Medical and Pediatric Oncology. Supplement

JF - Medical and Pediatric Oncology. Supplement

ER -